hepatocyte growth factor
AssetAlso KP-100IT
Activates MET signaling to promote neuronal survival and tissue repair after spinal cord injury.
- Stage
- Phase 3
- Modality
- Protein or enzyme
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Acute spinal cord injury
Phase 3, Unknown, NCT04475224, clinicaltrials.gov, Oct 29, 2026
In the full profile
- Owner and partners1
- Trials1
- Evidence for its targets1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.